Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

[68Ga]Ga-FAPI PET/CT for Response Evaluation During Immune Checkpoint Inhibitor Therapy in Malignant Melanoma

NCT07215182 is registered in ClinicalTrials.gov with Barbara Malene Fischer as lead sponsor.

NCT NCT07215182
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07215182 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
[68Ga]Ga-FAPI PET/CT for Response Evaluation During Immune Checkpoint Inhibitor Therapy in Malignant Melanoma
Lead sponsor
Barbara Malene Fischer
Phase
Phase 2
Overall status
Recruiting
Start date
August 15, 2025
Completion date
February 20, 2027
Enrollment
20 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

malignant melanoma stage iv